European public procurement and grants data from official registers · Data as of 18 November 2026; updated daily.

Tenders

Hormonal drug tenders in Czechia

Hormonal drug tenders in Czechia: 219 listed on GranTender since 2024. The median awarded contract value is about €82,000 (132 contracts with a stated value). Buyers with the most tenders: Fakultní nemocnice Olomouc (37), Fakultní nemocnice Ostrava (25) and Institut klinické a experimentální medicíny (13); suppliers with the most contract awards: ViaPharma s.r.o. (11), Takeda Pharmaceuticals Czech Republic s.r.o. (10) and VIVAX Management (CZ), s.r.o. (7). Sources: Registr smluv, ISVZ (NIPEZ) and TED. In 2025 the median contract value was €100,000; 40% of contracts drew a single bid (2.5 bids on average). Data as of 18 November 2026; updated daily.

Tenders
219
Open tenders
0
Awards
366
Awarded value awarded
€28,316,995
Awarded value contract
€50,100,571
Awarded value framework ceiling
€15,953,484
Median contract value contract
≈ €97,000
Median contract value awarded
≈ €82,000
Median contract value framework ceiling
≈ €97,000
Average bids per contract
2.3
Tenders in 2025
91 +90% on 2024

Median: contracts with a stated value, rounded. Average bids: contracts where the number of bids is published.

Value kinds: awarded — the value in the award decision; contract — the value of the signed or amended contract; paid — the amount actually paid; framework ceiling — the maximum of a framework agreement, given with every winner, not money spent. Different kinds are never added together.

Open tenders

No records yet.

Latest tenders

TenderBuyerEstimated valueStatusPublished
Léčivé přípravky s obsahem injekčních forem glukokortikoidů 2026Fakultní nemocnice Hradec KrálovéCZK 14,406,400 (≈ €592,954)Closed13 October 2026
Léčivé přípravky s obsahem injekčních forem glukokortikoidů 2026Fakultní nemocnice Hradec KrálovéCZK 14,406,400 (≈ €592,954)Closed13 October 2026
LP s obsahem relugolixu 2026 - sdružený nákupFakultní nemocnice OlomoucCZK 9,656,817 (≈ €397,465)Closed10 September 2026
Kupní smlouva na vybavení pro kvantitativní analýzu hormonů - část b)Česká zemědělská univerzita v Praze—Awarded9 September 2026
DNS Výzva č. 102 H02AB04 - METHYLPREDNISOLON DEPOTNÍMěstská nemocnice Ostrava, příspěvková organizace—Awarded24 August 2026
DNS - Methylprednisolon II.Ústřední vojenská nemocnice - Vojenská fakultní nemocnice PrahaCZK 4,576,002 (≈ €188,344)Cancelled4 August 2026
DNS – Methylprednisolon-acetát (40 mg/ ml) II.Ústřední vojenská nemocnice - Vojenská fakultní nemocnice PrahaCZK 1,966,860 (≈ €80,954)Cancelled4 August 2026
Léčivé přípravky s obsahem solifenacinuFakultní nemocnice Hradec KrálovéCZK 2,165,000 (≈ €89,109)Awarded27 July 2026
Léčivé přípravky s obsahem solifenacinuFakultní nemocnice Hradec KrálovéCZK 2,165,000 (≈ €89,109)Awarded27 July 2026
Léčivé přípravky s obsahem solifenacinuFakultní nemocnice Hradec Králové—Awarded24 July 2026
Léčivé přípravky s obsahem účinné látky Vazopresin (Argipresin)Uherskohradišťská nemocnice a.s.CZK 1,053,294 (≈ €43,353)Awarded22 July 2026
Léčivé přípravky s obsahem účinné látky Vazopresin (Argipresin)Uherskohradišťská nemocnice a.s.—Awarded22 July 2026
Léčivé přípravky s obsahem sodné soli levothyroxinu - VEŘEJNÁ LÉKÁRNA IIFakultní nemocnice Hradec KrálovéCZK 2,200,000 (≈ €90,550)Awarded16 July 2026
Léčivé přípravky s obsahem sodné soli levothyroxinu - VEŘEJNÁ LÉKÁRNA IIFakultní nemocnice Hradec KrálovéCZK 2,200,000 (≈ €90,550)Awarded16 July 2026
Léčivé přípravky s obsahem sodné soli levothyroxinu - VEŘEJNÁ LÉKÁRNA IIFakultní nemocnice Hradec Králové—Awarded15 July 2026
Kortikosteroidy pro systémové použití III.Institut klinické a experimentální medicínyCZK 4,778,000 (≈ €196,658)Awarded15 July 2026
DYNAMICKÝ NÁKUPNÍ SYSTÉM PRO PRŮBĚŽNÉ A OPAKOVANÉ NÁKUPY LÉČIVÝCH PŘÍPRAVKŮ – Červenec_5/2026 - VOSORITIDVšeobecná fakultní nemocnice v Praze—Awarded15 July 2026
DNS – Hydrokortison tblÚstřední vojenská nemocnice - Vojenská fakultní nemocnice PrahaCZK 52,728 (≈ €2,170)Cancelled2 July 2026
DNS – Hydrokortison injÚstřední vojenská nemocnice - Vojenská fakultní nemocnice PrahaCZK 1,303,212 (≈ €53,639)Closed2 July 2026
DNS – TerlipresinÚstřední vojenská nemocnice - Vojenská fakultní nemocnice PrahaCZK 3,272,114 (≈ €134,677)Closed2 July 2026

Competition and prices

In 2025, half of the contracts were worth between €37,000 and €170,000, with a median of €100,000 (65 contracts with a stated awarded value). Contracts drew 2.5 bids on average (median 2) and 40% drew a single bid — based on 149 contracts with a known number of bids. Compared with 2024, in 2025 the median value rose 92% and the share of single-bid contracts fell from 47% to 40%. The usual procedures: open procedure (69%), other procedures (30%), restricted procedure (1%) — of 163 tenders with a stated procedure.

The most contracts went to ViaPharma s.r.o. (11), Takeda Pharmaceuticals Czech Republic s.r.o. (10) and VIVAX Management (CZ), s.r.o. (7) — together 8% of all contracts.

YearContractsMedian valueMiddle half of valuesBids on averageSingle bid
202487€52,000€26,000 – €110,0001.747% (38)
2025167€100,000€37,000 – €170,0002.540% (149)
2026 (so far)105€69,000 (contract value)€15,000 – €330,0002.245% (85)
All years361€97,000 (contract value)€23,000 – €310,0002.343% (272)

Values: contracts with a stated value in EUR, each value kind on its own (awarded or contract value), approximate (±3 %). Bids: contracts of procedures with competition whose number of bids the source publishes (1–100 bids); the sources publish it for some contracts only (TED ≈ 3 in 4, Spain all, Poland about half, Italy few), so each figure states its base and is shown from 20 contracts. A contract counts in the year of its award (else of its tender). Figures as of 13 November 2026, recomputed every week.

Where you have a chance

Since 1 November 2024, 42% of the 238 contracts with a known number of bids had a single bid; the median was 2 bids. The number of bids is known for 238 of the 278 contracts from procedures with competition.

Buyers who often get few offers

The buyers below usually received one or two offers per contract — an offer from you would stand out.

In the last 12 months, 1 company won its first contract in our records here — 3% of the 37 contracts (our records start on 1 January 2024).

Contracts awarded since 1 November 2024 (the last 24 months). Bids as the source publishes them, 1 to 100 per contract, in procedures with competition only (a direct award has one offer by design). As of 13 November 2026.

Main CPV divisions

CPV codes of this topic

  • 33640000 Medicinal products for the genitourinary system and hormones

A tender belongs here when its main CPV code starts with one of these codes; a tender without a usable CPV code (or with a general one) is matched by words of its title. A tender may belong to up to three topics.

Hormonal drugs and contraceptives in neighbouring countries

Today, 3 tenders in the same niche are open in neighbouring countries.

Public tenders in the EU and the EEA are open to companies from every EU and EEA country on the same terms as local ones, and to companies from countries with a procurement agreement with the EU (such as Switzerland, the United Kingdom and Ukraine) for the contracts it covers. Open means the deadline has not passed (today's date). Neighbours: countries with a land border, a fixed link or a short sea crossing.

Market reports

Hormonal drugs and contraceptives by city

Hormonal drugs and contraceptives in other countries

Hormonal drugs and contraceptives across Europe

Topics in Health, medical equipment and medicines

Questions and answers

Where can I find hormonal drug tenders in Czechia?
GranTender lists them in one place, from Registr smluv, ISVZ (NIPEZ) and TED, with their buyers, winners and contract values. Search in one country at a time (the first 5 results) is free; search across all countries at once, full result lists, saved keywords with an e-mail once a week and exports come with a plan.
Who wins the most hormonal drug tenders in Czechia?
By number of contracts won: ViaPharma s.r.o. (11), Takeda Pharmaceuticals Czech Republic s.r.o. (10), VIVAX Management (CZ), s.r.o. (7).
Which buyers publish the most hormonal drug tenders in Czechia?
By number of tenders: Fakultní nemocnice Olomouc (37), Fakultní nemocnice Ostrava (25), Institut klinické a experimentální medicíny (13).
Which CPV codes belong to “Hormonal drugs and contraceptives”?
33640000 Medicinal products for the genitourinary system and hormones; plus tenders without a usable CPV code whose title names the topic.
How many bids do hormonal drug tenders in Czechia receive on average?
In 2025, contracts drew 2.5 bids on average (median 2) and 40% drew a single bid — based on 149 contracts with a known number of bids.
How much are contracts for hormonal drug tenders in Czechia worth?
In 2025, half of the contracts were worth between €37,000 and €170,000, with a median of €100,000 (65 contracts with a stated awarded value). Compared with 2024, in 2025 the median value rose 92% and the share of single-bid contracts fell from 47% to 40%.
Which procedures are used for hormonal drug tenders in Czechia?
The usual procedures: open procedure (69%), other procedures (30%), restricted procedure (1%) — of 163 tenders with a stated procedure.
Which buyers get few offers in hormonal drug tenders in Czechia?
Since 1 November 2024, these buyers usually received one or two offers per contract: Fakultní nemocnice Olomouc (median 1 bid over 51 contracts), Městská nemocnice Ostrava, příspěvková organizace (median 2 bids over 47 contracts) and Fakultní nemocnice Ostrava (median 2 bids over 12 contracts). Since 1 November 2024, 42% of the 238 contracts with a known number of bids had a single bid; the median was 2 bids.

CPV 2008 (Regulation (EC) No 213/2008), © European Union, Publications Office — via the eForms SDK, CC BY 4.0.